Mani Mohindru's Net Worth
$860 Thousand
Who is Mani Mohindru?
Mani Mohindru does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cara Therapeutics, Inc., CURIS INC, CytomX Therapeutics, Inc., and Cardiff Oncology, Inc..
SEC CIK
Mani Mohindru's CIK is 0001664708
Past Insider Trading and Trends
2019 was Mani Mohindru's most active year for acquiring shares with 5 total transactions. Mani Mohindru's most active month to acquire stocks was the month of May. 2019 was Mani Mohindru's most active year for disposing of shares, totalling 6 transactions. Mani Mohindru's most active month to dispose stocks was the month of February. 2019 saw Mani Mohindru paying a total of $751,816.32 for 145,138 shares, this is the most they've acquired in one year. In 2019 Mani Mohindru cashed out on 114,195 shares for a total of $1,376,941.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.532
CFO & Chief Strategy Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.81% | 3.58K |
$17.05 | -$81,072.75 | 17.44K |
Scheduled
|
Dec 2 - Dec 4
| ||
Form 4
|
—
|
0
|
$19.53 | -$409,495.14 | 13.86K |
Scheduled
|
Jul 15
| ||
Form 4
| +72.73% | 5.84K |
$21.39 | -$53,389.44 | 13.86K |
Scheduled
|
May 28 - May 29
| ||
Form 4
|
—
|
0
|
$16.59 | -$81,167.46 | 8.03K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| -35.93% | -4.50K |
$12.55 | -$56,475.00 | 8.03K |
Scheduled
|
Dec 28
| ||
Form 4
|
∞
| 12.53K |
—
|
—
| 12.53K |
Dec 27
| |||
Form 4
|
—
|
0
|
$16.28 | -$71,226.48 |
0
|
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$17.13 | -$98,337.46 |
0
|
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CURIS INC (CRIS) Snapshot price: $9.38
Chief Strategy Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardiff Oncology, Inc. (CRDF) Snapshot price: $1.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||